5 May 2020PatentsSarah Morgan

USPTO launches COVID-19 patent platform

The US Patent and Trademark Office (USPTO) has launched a platform aimed at supporting patent owners wanting to license technology related to the “prevention, treatment, and diagnosis” of COVID-19.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

UKIPO extends ‘interrupted days’; Fed Circuit increases phone hearings

12 May 2020 IP offices and courts around the world are updating measures aimed at minimising disruption as the COVID-19 pandemic continues.

Patents

USPTO announces COVID-19 deferred-fee patent application programme

18 September 2020 The United States Patent and Trademark Office has unveiled a deferred-fee provisional patent application pilot programme for inventions that combat COVID-19.

Patents

Biden backs TRIPS waiver for COVID-19 vaccines

6 May 2021 President Joe Biden has backed the waiving of IP rights for COVID-19 vaccines following mounting pressure from countries, charities and industry bodies.

On our radar...

Philip Morris case triggers AIPPI call for EPO action

Penn State prevails in trademark dispute with Vintage Brand over retro logos

Google: Ex-engineer ‘touted dominion over the trade secrets he stole’

‘Trade secrets can be emotional’: Seth Gerber, Morgan Lewis

Private equity eyes controlling interest in Anaqua

Motorola can’t enforce ‘multiple’ US Hytera damages in UK

UK firms Venner Shipley and AA Thornton combine

USPTO launches COVID-19 patent platform

More on this story

Editor's picks

Editor's picks

More articles